Kwee Yong

University College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Janet Dunn

Professor of Clinical Trials and Head of Cancer trials

University of Warwick

UNITED KINGDOM

View details

Karthik Ramasamy

University of Oxford

UNITED KINGDOM

View details

Gulnaz Iqbal

Associate Professor

University of Warwick

UNITED KINGDOM

View details

Orla McCourt

Honorary Clinical Lecturer

University College London

UNITED KINGDOM

View details

Martin Kaiser

Professor of Haematology

The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust

UNITED KINGDOM

View details

Guy Pratt

UNITED KINGDOM

View details

Joanne Land

University College London

UNITED KINGDOM

View details

Dean Smith

Associate Professor

University of Nottingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kwee Yong

Research Interests

Explore related searches

Contact this professor

Articles (13)

Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper

Challenges in designing and running smouldering myeloma interventional clinical trials

Functional and psychological impact of minimal residual disease assessment on patients with multiple myeloma

Exercise prehabilitation for people with myeloma undergoing autologous stem cell transplantation: results from PERCEPT pilot randomised controlled trial

Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study

Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study

High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis

Applying current smouldering myeloma risk models to a UK single‐centre cohort and clinical features at progression

Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial

BCMA CARs in multiple myeloma: room for more?

Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set

A real‐world study of panobinostat, weekly bortezomib and dexamethasone in a very heavily pretreated population of multiple‐myeloma patients

Stratifying risk of infection and response to therapy in patients with myeloma: a prognostic study

Collaborators (8)

Janet Dunn

Karthik Ramasamy

Gulnaz Iqbal

Orla McCourt

Martin Kaiser

Guy Pratt

Joanne Land

Dean Smith

Make your next move.